ZA931858B - Method of producing porous delivery devices - Google Patents

Method of producing porous delivery devices

Info

Publication number
ZA931858B
ZA931858B ZA931858A ZA931858A ZA931858B ZA 931858 B ZA931858 B ZA 931858B ZA 931858 A ZA931858 A ZA 931858A ZA 931858 A ZA931858 A ZA 931858A ZA 931858 B ZA931858 B ZA 931858B
Authority
ZA
South Africa
Prior art keywords
menthol
pct
formulation
delivery devices
date sep
Prior art date
Application number
ZA931858A
Other languages
English (en)
Inventor
Julian B Lo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA931858B publication Critical patent/ZA931858B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Silicon Compounds (AREA)
  • Silicon Polymers (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
ZA931858A 1992-03-17 1993-03-16 Method of producing porous delivery devices ZA931858B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85270292A 1992-03-17 1992-03-17

Publications (1)

Publication Number Publication Date
ZA931858B true ZA931858B (en) 1994-09-16

Family

ID=25314024

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931858A ZA931858B (en) 1992-03-17 1993-03-16 Method of producing porous delivery devices

Country Status (23)

Country Link
US (1) US5529789A (da)
EP (1) EP0630237B1 (da)
JP (1) JP2559206B2 (da)
AT (1) ATE140625T1 (da)
AU (1) AU669680B2 (da)
BR (1) BR9207104A (da)
CA (1) CA2131089C (da)
CZ (1) CZ225894A3 (da)
DE (1) DE69212503T2 (da)
DK (1) DK0630237T3 (da)
ES (1) ES2089581T3 (da)
FI (1) FI109658B (da)
GR (1) GR3020666T3 (da)
HU (1) HUT75616A (da)
IL (1) IL105016A (da)
MX (1) MX9301435A (da)
MY (1) MY109151A (da)
NO (1) NO308154B1 (da)
NZ (1) NZ247168A (da)
RU (1) RU94041221A (da)
TW (1) TW360542B (da)
WO (1) WO1993018757A1 (da)
ZA (1) ZA931858B (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616344A (en) * 1994-06-14 1997-04-01 Fuisz Technologies Ltd. Apparatus and process for strengthening low density compression dosage units and product therefrom
US5837287A (en) * 1994-10-28 1998-11-17 R P Scherer Corporation Process for preparing solid pharmaceutical dosage forms
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
WO1998002182A1 (en) * 1996-07-12 1998-01-22 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
GB9700878D0 (en) * 1997-01-17 1997-03-05 Scherer Ltd R P Dosage forms and method for ameliorating male erectile dysfunction
US20030138485A1 (en) * 1998-01-14 2003-07-24 Daiichi Pharmaceutical Co., Ltd. Disintegrant
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
RU2191582C2 (ru) * 2000-04-05 2002-10-27 Хазанов Вениамин Абрамович Фармацевтические композиции на основе нестероидных противовоспалительных средств
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법
DE10038571A1 (de) * 2000-08-03 2002-02-14 Knoll Ag Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
IL159287A0 (en) 2001-06-28 2004-06-01 Ucb Farchim Sa Tablet comprising cetirizine and pseudoephedrine
ES2334991T3 (es) * 2002-03-26 2010-03-18 Teva Pharmaceutical Industries Ltd. Microparticulas de farmaco.
US20030215498A1 (en) * 2002-05-17 2003-11-20 Harland Ronald S. Rapidly disintegrating comressed tablets comprising biologically active compounds
DE10224087A1 (de) * 2002-05-31 2003-12-11 Symrise Gmbh & Co Kg Kompaktiertes Menthol
HU227142B1 (en) * 2003-07-02 2010-08-30 Egis Gyogyszergyar Nyilvanosan Capsule of improved release containing fluconazole
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
BRPI0519212A2 (pt) * 2004-12-23 2009-01-06 Mcneil Ppc Inc composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial
US20070051741A1 (en) 2005-09-02 2007-03-08 Kraft Foods Holdings, Inc. Methods for the application of ingredients to the inside of a straw
RU2478375C2 (ru) 2007-03-13 2013-04-10 ДАЙНИППОН СУМИТОМО ФАРМА Ко., ЛТД. Распадающаяся во рту таблетка
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
AR081808A1 (es) * 2010-03-26 2012-10-24 Philip Morris Prod Procedimiento para producir una estructura continua de un material encapsulado
US9993019B2 (en) * 2010-03-26 2018-06-12 Philip Morris Usa Inc. Method for making particle of a hydrophobic additive and a polysaccharide coating and tobacco products containing particle of a hydrophobic additive and a polysaccharide coating
EP3193843A1 (en) 2014-09-17 2017-07-26 Steerlife India Private Limited Effervescent composition and method of making it
WO2017098481A1 (en) 2015-12-12 2017-06-15 Steerlife India Private Limited Effervescent compositions of metformin and processes for preparation thereof
CN106943367B (zh) * 2016-01-06 2020-07-14 山东新时代药业有限公司 一种马来酸阿法替尼片及其制备方法
US10492522B2 (en) * 2017-05-03 2019-12-03 R.J. Reynolds Tobacco Company Flavored menthol-containing objects for application to smoking article components

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
GB8514090D0 (en) * 1985-06-04 1985-07-10 Sandoz Ltd Organic compounds
FR2561916B1 (fr) * 1984-03-30 1987-12-11 Lafon Labor Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau
JPH01143801A (ja) * 1987-12-01 1989-06-06 Nitto Denzai Kk 崩壊性成形体
US5417985A (en) * 1989-07-20 1995-05-23 Farmalyoc Solid and porous single dosage form comprising particles in the form of beads and its preparation
US5215756A (en) * 1989-12-22 1993-06-01 Gole Dilip J Preparation of pharmaceutical and other matrix systems by solid-state dissolution
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics

Also Published As

Publication number Publication date
NO943461L (no) 1994-09-16
US5529789A (en) 1996-06-25
HU9402675D0 (en) 1994-11-28
BR9207104A (pt) 1995-12-05
NO943461D0 (no) 1994-09-16
JPH07501829A (ja) 1995-02-23
CA2131089A1 (en) 1993-09-18
IL105016A (en) 1996-09-12
GR3020666T3 (en) 1996-10-31
JP2559206B2 (ja) 1996-12-04
NZ247168A (en) 1995-03-28
AU669680B2 (en) 1996-06-20
MY109151A (en) 1996-12-31
FI944309A0 (fi) 1994-09-16
CA2131089C (en) 1998-05-26
MX9301435A (es) 1993-10-01
DE69212503T2 (de) 1996-12-12
AU3057592A (en) 1993-10-21
EP0630237A1 (en) 1994-12-28
DE69212503D1 (de) 1996-08-29
DK0630237T3 (da) 1996-08-26
IL105016A0 (en) 1993-07-08
ATE140625T1 (de) 1996-08-15
RU94041221A (ru) 1996-07-10
NO308154B1 (no) 2000-08-07
HUT75616A (en) 1997-05-28
FI109658B (fi) 2002-09-30
ES2089581T3 (es) 1996-10-01
TW360542B (en) 1999-06-11
CZ225894A3 (en) 1995-01-18
EP0630237B1 (en) 1996-07-24
WO1993018757A1 (en) 1993-09-30
FI944309A (fi) 1994-09-16

Similar Documents

Publication Publication Date Title
ZA931858B (en) Method of producing porous delivery devices
CS305091A3 (en) Pharmaceutical free of a solvent for per oral administration with delayed liberation of an active component and process for preparing thereof
HU76547A2 (en) Process for producing pharmaceutical compositions containing agent in polymer-matrix and in solid solution form and these medicaments
KR0173989B1 (en) Preparation of pharmaceutical and other matrix systems by solid-state dissolution
DE69429119D1 (de) Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
GB9310412D0 (en) Nasal nicotine system
GR3026338T3 (en) High release solid preparation, preparation and use thereof
GR3023242T3 (en) Process for the preparation of solid sustained release pharmaceutical forms
CA2138125A1 (en) Process for Making Compact Detergent Compositions
HK1038310A1 (en) Compositions and methods for treating intracellular infections.
HU9202540D0 (en) Method for producing pharmaceutical preparatives containing new 1-benzo-pyrqno(4,3-c)pyrazole derivatives and their active agents
Barthel Homogenisation and cooling of used sand-a major factor in the reduction of mould and foundry scrap